Iovance Biotherapeutics, Inc.
IOVA
$2.83
$0.155.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 359.71M | 323.78M | 397.49M | 412.54M | 356.20M |
| Total Receivables | 70.94M | 69.34M | 55.77M | 31.60M | 234.00K |
| Inventory | 65.55M | 51.52M | 38.58M | 27.85M | 17.62M |
| Prepaid Expenses | 15.89M | 12.38M | 6.74M | 10.18M | 11.49M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 559.00K | -- | -- | 74.00K | -- |
| Total Current Assets | 512.65M | 457.02M | 498.58M | 482.26M | 385.53M |
|
|
|||||
| Total Current Assets | 512.65M | 457.02M | 498.58M | 482.26M | 385.53M |
| Net Property, Plant & Equipment | 162.49M | 164.28M | 179.26M | 180.08M | 183.31M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 285.36M | 282.40M | 306.64M | 295.30M | 294.30M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.25M | 6.73M | 6.64M | 6.68M | 6.69M |
| Total Assets | 966.74M | 910.43M | 991.12M | 964.32M | 869.83M |
|
|
|||||
| Total Accounts Payable | 28.49M | 27.51M | 31.69M | 20.42M | 25.70M |
| Total Accrued Expenses | 77.49M | 75.19M | 72.76M | 60.10M | 44.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.50M | 12.90M | 11.55M | 11.44M | 11.08M |
| Total Finance Division Other Current Liabilities | 7.22M | 6.75M | 2.06M | 1.69M | 1.66M |
| Total Other Current Liabilities | 7.22M | 6.75M | 2.06M | 1.69M | 1.66M |
| Total Current Liabilities | 122.69M | 122.34M | 118.06M | 93.64M | 83.21M |
|
|
|||||
| Total Current Liabilities | 122.69M | 122.34M | 118.06M | 93.64M | 83.21M |
| Long-Term Debt | -- | 1.00M | 1.00M | 1.00M | 1.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 44.22M | 44.37M | 66.39M | 69.25M | 72.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.96M | 32.32M | 32.22M | 31.90M | 33.30M |
| Total Liabilities | 198.88M | 200.02M | 217.66M | 195.78M | 189.81M |
|
|
|||||
| Common Stock & APIC | 3.26B | 3.10B | 3.06B | 2.99B | 2.81B |
| Retained Earnings | -2.50B | -2.38B | -2.31B | -2.22B | -2.13B |
| Treasury Stock & Other | 6.29M | -1.05M | 16.24M | 526.00K | 116.00K |
| Total Common Equity | 767.86M | 710.40M | 773.45M | 768.54M | 680.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.00K | 3.00K | 3.00K | 3.00K | 3.00K |
|
|
|||||
| Total Common Equity | 767.86M | 710.40M | 773.45M | 768.54M | 680.02M |
| Total Preferred Equity | 2.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 767.87M | 710.41M | 773.46M | 768.54M | 680.02M |
|
|
|||||